Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Recap by typeshit. Post by Chris Williamson on X.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.
Loading…